ArticleEMBO molecular medicine2020

Combined targeting of G protein-coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN-null triple negative breast cancer.

Davide Zecchin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.